Literature DB >> 22422295

Multimodality evaluation of cardiac sarcoidosis.

Osamu Manabe1, Noriko Oyama-Manabe, Hiroshi Ohira, Hiroyuki Tsutsui, Nagara Tamaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22422295     DOI： 10.1007/s12350-012-9543-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  3 in total

1.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Authors:  Shinji Ishimaru; Ichizo Tsujino; Toshiki Takei; Eriko Tsukamoto; Shinji Sakaue; Mitsunori Kamigaki; Naofumi Ito; Hiroshi Ohira; Daisuke Ikeda; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur Heart J       Date:  2005-04-04       Impact factor: 29.983

Review 2.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

3.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

Authors:  Jan-Peter Smedema; Gabriel Snoep; Marinus P G van Kroonenburgh; Robert-Jan van Geuns; Willem R M Dassen; Anton P M Gorgels; Harry J G M Crijns
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094
  3 in total
  2 in total

1.  Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Hiroshi Ohira; Keiichiro Yoshinaga; Takahiro Sato; Alisa Klaipetch; Noriko Oyama-Manabe; Yoichi M Ito; Ichizo Tsujino; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-29       Impact factor: 9.236

2.  Radiopharmaceutical tracers for cardiac imaging.

Authors:  Osamu Manabe; Tatsuya Kikuchi; Arthur J H A Scholte; Mohammed El Mahdiui; Ryuichi Nishii; Ming-Rong Zhang; Eriko Suzuki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2017-12-01       Impact factor: 5.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.